Referred to the Senate Health & Long-Term Care Committee on January 25, 2022
Referred to the Senate Behavioral Health Subcommittee to Health & Long Term Care Committee on February 16, 2022
Referred to the Senate Rules Committee on February 17, 2022
Amendment offered in the Senate on March 1, 2022
Expands the overdose and suicide fatality reviews to include reviews of fatalities due to withdrawal related to substances of abuse such as opiates, benzodiazepines, and alcohol. Requires the reviews to be shared with the Department of Health, subject to the confidentiality restrictions.
The amendment passed by voice vote in the Senate on March 1, 2022